> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension on Outsourcing Facility Reports
- URL: https://www.fdaweb.com/info-collection-extension-on-outsourcing-facility-reports/
- Published: 2019-07-16T12:00:00.000Z
- Updated: 2026-09-15T01:38:13.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144537

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act” (OMB Control Number 0910-0827). Outsourcing facilities must register with and submit regular reports identifying the drugs compounded by facility during the previous six-month period. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-15124.pdf?ref=fdaweb.com).